Press release
Anaplastic Thyroid Cancer Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | AffyImmune Therapeutics, Faron Pharmaceuticals Ltd, Codiak BioSciences, Shanghai Henlius Biotech, Taizh
"Anaplastic Thyroid Cancer Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Anaplastic Thyroid Cancer Market.
The Anaplastic Thyroid Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Anaplastic Thyroid Cancer Pipeline Report: https://www.delveinsight.com/sample-request/anaplastic-thyroid-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Anaplastic Thyroid Cancer treatment therapies with a considerable amount of success over the years.
• Anaplastic Thyroid Cancer companies working in the treatment market are AffyImmune Therapeutics, Faron Pharmaceuticals Ltd, Codiak BioSciences, Shanghai Henlius Biotech, Taizhou Hanzhong biomedical co. LTD, Merck & Co, Takeda Oncology, and others, are developing therapies for the Anaplastic Thyroid Cancer treatment
• Emerging Anaplastic Thyroid Cancer therapies in the different phases of clinical trials are- AIC100, FP-1305, CDK-002, HLX208, HX008, Pembrolizumab, Sapanisertib, and others are expected to have a significant impact on the Anaplastic Thyroid Cancer market in the coming years.
• In February 2022, A Phase II trial of pembrolizumab was started by Stanford University and Merck Sharp & Dohme LLC for patients with metastatic or locally advanced anaplastic/undifferentiated thyroid carcinoma. This single-arm, open-label study aims to assess pembrolizumab therapy's efficacy in treating anaplastic thyroid cancer in patients who are not responding to other curative treatments.
Anaplastic Thyroid Cancer Overview
Two to three percent of thyroid gland neoplasms are anaplastic thyroid carcinomas, sometimes referred to as undifferentiated thyroid carcinomas. These tumors are uncommon, extremely aggressive, and dangerous. With a very bad prognosis, anaplastic thyroid carcinoma remains one of the most dangerous diseases in the world.
Get a Free Sample PDF Report to know more about Anaplastic Thyroid Cancer Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/anaplastic-thyroid-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Anaplastic Thyroid Cancer Drugs Under Different Phases of Clinical Development Include:
• AIC100: AffyImmune Therapeutics
• FP-1305: Faron Pharmaceuticals Ltd
• CDK-002: Codiak BioSciences
• HLX208: Shanghai Henlius Biotech
• HX008: Taizhou Hanzhong biomedical co. LTD
• Pembrolizumab: Merck & Co
• Sapanisertib: Takeda Oncology
Anaplastic Thyroid Cancer Route of Administration
Anaplastic Thyroid Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• NA
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Anaplastic Thyroid Cancer Molecule Type
Anaplastic Thyroid Cancer Products have been categorized under various Molecule types, such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Anaplastic Thyroid Cancer Pipeline Therapeutics Assessment
• Anaplastic Thyroid Cancer Assessment by Product Type
• Anaplastic Thyroid Cancer By Stage and Product Type
• Anaplastic Thyroid Cancer Assessment by Route of Administration
• Anaplastic Thyroid Cancer By Stage and Route of Administration
• Anaplastic Thyroid Cancer Assessment by Molecule Type
• Anaplastic Thyroid Cancer by Stage and Molecule Type
DelveInsight's Anaplastic Thyroid Cancer Report covers around 8+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Anaplastic Thyroid Cancer product details are provided in the report. Download the Anaplastic Thyroid Cancer pipeline report to learn more about the emerging Anaplastic Thyroid Cancer therapies at:
https://www.delveinsight.com/sample-request/anaplastic-thyroid-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Anaplastic Thyroid Cancer Therapeutics Market include:
Key companies developing therapies for Anaplastic Thyroid Cancer are - Eisai Co. Ltd., Exelixis Inc., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Medtronic Plc, Merck KGaA, Novartis AG, Pfizer Inc., Akorn Inc., Amneal Pharmaceuticals Inc., Bayer AG, Bristol Myers Squibb Co., Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Viatris Inc., and others.
Anaplastic Thyroid Cancer Pipeline Analysis:
The Anaplastic Thyroid Cancer pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Anaplastic Thyroid Cancer with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Anaplastic Thyroid Cancer Treatment.
• Anaplastic Thyroid Cancer key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Anaplastic Thyroid Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Anaplastic Thyroid Cancer market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Anaplastic Thyroid Cancer drugs and therapies-
https://www.delveinsight.com/sample-request/anaplastic-thyroid-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Anaplastic Thyroid Cancer Pipeline Market Drivers
• Rising prevalence of thyroid cancer, improving Healthcare Infrastructure, demand for New and Effective Drugs, increasing awareness about anaplastic thyroid cancer are some of the important factors that are fueling the Anaplastic Thyroid Cancer Market.
Anaplastic Thyroid Cancer Pipeline Market Barriers
• However, high cost of treatment, adverse effects associated with the chemotherapy and other factors are creating obstacles in the Anaplastic Thyroid Cancer Market growth.
Scope of Anaplastic Thyroid Cancer Pipeline Drug Insight
• Coverage: Global
• Key Anaplastic Thyroid Cancer Companies: AffyImmune Therapeutics, Faron Pharmaceuticals Ltd, Codiak BioSciences, Shanghai Henlius Biotech, Taizhou Hanzhong biomedical co. LTD, Merck & Co, Takeda Oncology, and others
• Key Anaplastic Thyroid Cancer Therapies: AIC100, FP-1305, CDK-002, HLX208, HX008, Pembrolizumab, Sapanisertib, and others
• Anaplastic Thyroid Cancer Therapeutic Assessment: Anaplastic Thyroid Cancer current marketed and Anaplastic Thyroid Cancer emerging therapies
• Anaplastic Thyroid Cancer Market Dynamics: Anaplastic Thyroid Cancer market drivers and Anaplastic Thyroid Cancer market barriers
Request for Sample PDF Report for Anaplastic Thyroid Cancer Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/anaplastic-thyroid-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Anaplastic Thyroid Cancer Report Introduction
2. Anaplastic Thyroid Cancer Executive Summary
3. Anaplastic Thyroid Cancer Overview
4. Anaplastic Thyroid Cancer- Analytical Perspective In-depth Commercial Assessment
5. Anaplastic Thyroid Cancer Pipeline Therapeutics
6. Anaplastic Thyroid Cancer Late Stage Products (Phase II/III)
7. Anaplastic Thyroid Cancer Mid Stage Products (Phase II)
8. Anaplastic Thyroid Cancer Early Stage Products (Phase I)
9. Anaplastic Thyroid Cancer Preclinical Stage Products
10. Anaplastic Thyroid Cancer Therapeutics Assessment
11. Anaplastic Thyroid Cancer Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Anaplastic Thyroid Cancer Key Companies
14. Anaplastic Thyroid Cancer Key Products
15. Anaplastic Thyroid Cancer Unmet Needs
16 . Anaplastic Thyroid Cancer Market Drivers and Barriers
17. Anaplastic Thyroid Cancer Future Perspectives and Conclusion
18. Anaplastic Thyroid Cancer Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Anaplastic Thyroid Cancer Market
DelveInsight's 'Anaplastic Thyroid Cancer Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Anaplastic Thyroid Cancer Epidemiology
DelveInsight's 'Anaplastic Thyroid Cancer Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Hyaluronic Acid Viscosupplementation Market
https://www.delveinsight.com/report-store/hyaluronic-acid-viscosupplementation-market
The Hyaluronic Acid Viscosupplementation Market By Treatment Type (Single Injection, Three Injections, And Five Injections), By End-User (Hospitals, Specialty Clinics, And Others), And By Geography Is Expected To Grow At A Steady CAGR forecast till 2028 owing to the increasing prevalence of osteoarthritis, particularly among the geriatric population and increasing demand for non-surgical treatment options for osteoarthritis.
Frozen Food Market
https://www.delveinsight.com/report-store/frozen-food-market
Frozen Foods Market By Product (Fruits & Vegetables, Dairy Products, Meat Products, Seafood Products, And Others), By Product Type (Raw Material, Half-Cooked And Ready-To-Eat), By Distribution Channel (Hypermarkets And Supermarkets, General Stores, E-Commerce, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rise in the demand for ready-to-eat dishes, overall increase in the average income of individuals, rising work culture in countries, lack of time, usage of foods for extended period and others, along with the rising advancements in delivering quality and preservative-free frozen foods across the globe.
Intrauterine Pressure Catheters Market
https://www.delveinsight.com/report-store/intrauterine-pressure-catheters-market
Intrauterine Pressure Catheters Market By Product (Fluid-Filled Catheters And Transducer Tip Catheters), By End-User (Hospitals, Ambulatory Surgical Centers (ASCS), And Specialty Clinics), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing number complications in pregnancy and rising focus on maternal and fetal care across the globe.
PET-MRI Systems Market
https://www.delveinsight.com/report-store/pet-mri-systems-market
PET-MRI Systems Market By Phase (Preclinical And Clinical), By Type (Traditional PET-MRI Systems And Helium-Free PET-MRI Systems), By End-User (Hospitals, Diagnostic Centers, Academic & Research Institutes, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the increasing prevalence of various cancer, neurological disorders and the escalating burden of geriatric population prone to various chronic diseases across the globe.
Transcatheter Heart Valve Replacement Devices Market
https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
Transcatheter Heart Valve Replacement Market By Product (Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, And Transcatheter Pulmonary Valve Replacement), By Application (Aortic Valve Stenosis, Aortic Valve Regurgitation, Mitral Valve Stenosis, Mitral Valve Regurgitation, And Others), By End-User (Hospitals, Specialty Clinics, And Others) and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing number valvular disease, aortic stenosis disorder, among other cardiovascular disorders and the presence of robust number of devices in pipeline across the globe.
Vaginal Slings Market
https://www.delveinsight.com/report-store/vaginal-slings-market
Vaginal Slings Market By Type (Transobturator Slings, Tension-Free Vaginal Tape Sling, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the increasing prevalence of urinary incontinence and increasing aging population prone to stress urinary incontinence and weakening of pelvic floor across the globe.
Prostate Cancer Market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
DelveInsight's "Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Prostate Cancer, historical and forecasted epidemiology as well as the Prostate Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Gene Therapy Market
https://www.delveinsight.com/report-store/gene-therapy-market
Gene Therapy Market By Vector Type (Viral And Non-Viral), By Delivery Type (Ex Vivo And In Vivo), By Indication (Neurological, Oncological, Hematological, Ophthalmological, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the rising therapeutic value of gene therapy and surge in research and development activities for gene therapy.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anaplastic Thyroid Cancer Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | AffyImmune Therapeutics, Faron Pharmaceuticals Ltd, Codiak BioSciences, Shanghai Henlius Biotech, Taizh here
News-ID: 3269642 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
